← Back to Screener
Greenland Mines Ltd Warrant (GRMLW)
Price$0.26
Favorite Metrics
Price vs S&P 500 (4W)15.69%
All Metrics
Price vs S&P 500 (YTD)67.55%
10-Day Avg Trading Volume0.03M
3-Month Avg Trading Volume0.02M
52-Week High$0.37
Year-to-Date Return78.29%
5-Day Price Return10.02%
Month-to-Date Return29.68%
52-Week Low$0.08
Industry Peers — Biological Products(90)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
GRMLWGreenland Mines Ltd Warrant | — | — | — | — | $0.26 |
| AMGNAmgen Inc | 4.81x | 9.07% | 73.95% | 2.93% | $329.59 |
| GILDGilead Sciences Inc | 5.48x | 3.48% | 79.35% | 133.64% | $133.52 |
| ARGXargenx SE American Depositary Shares | 11.79x | 89.56% | 150.91% | — | $813.28 |
| BIIBBiogen Inc. Common Stock | 2.97x | 2.22% | 75.69% | -18.77% | $197.95 |
| BNTXBioNTech SE American Depositary Share | 7.95x | -11.81% | 82.18% | — | $93.34 |
| MRNAModerna, Inc. Common Stock | 9.43x | -29.97% | 35.01% | — | $52.88 |
| NBIXNeurocrine Biosciences Inc | 5.32x | 21.45% | 98.18% | 2.31% | $150.59 |
| EXELExelixis Inc | 5.22x | 6.85% | 96.39% | 31.10% | $49.71 |
| KRYSKrystal Biotech, Inc. Common Stock | 23.16x | 33.95% | 94.08% | — | $312.88 |
| IBRXImmunityBio, Inc. Common Stock | 74.65x | 668.31% | 99.34% | — | $8.11 |
About
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.